Apelin and vascular endothelial growth factor are associated with mobilization of endothelial progenitor cells after acute myocardial infarction

Journal of Biomedical Research

Volumn 26, Issue 6, 2012, Pages 400-409

  Ye, Jiaxin ^a   Ni, Ping ^a   Kang, Lina ^a   Xu, Biao ^a  

^a THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

Author keywords

Apelin; Endothelial progenitor cells (EPCs); Stromal cell derived growth factor 1 (SDF 1); Vascular endothelial growth factor (VEGF)

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; APELIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CD133 ANTIGEN; CD34 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENDOTHELIAL PROGENITOR CELL; FEMALE; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STEM CELL MOBILIZATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 84870925920     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.7555/JBR.26.20120052     Document Type: Article

References (52)

1. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
2. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 1999, 85:221-228.
3. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Wil-liams M, et al. Expression of VEGFR-2 and AC133 by circulating human CD34 (+) cells identifies a population of functional endothelial precursor. Blood 2000, 95:952-958.
4. Hristov M, Erl W, Weber PC Endothelial progenitor cells: Mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 2003, 23:1185-1189.
5. Dignat-George F, Sampol J Circulating endothelial cells in vascular disorders: new insights into an old concept. Eur J Haematol 2000, 65:215-220.
6. Mutin M, Canavy I, Blann A, Bory M, Sampol J, Dignat-George F Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood 1999, 93:2951-2958.
7. Makin A, Chung NAY, Silverman SH, Blann A, Lip GY Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Relationship with von Willebrand factor and tissue factor. Eur Heart J 2004, 25:371-376.
8. Insner JM, Asahara T Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest 1999, 103:1231-1236.
9. Moore MA, Hattori K, Heissig B, Shieh JH, Dias S, Crystal RG, et al. Mobilization of endothelial and hematopoietic stem and progenitor cells by adenovector-mediated elevation of serum levels of SDF-1, VEGF, and angiopoietin-1. Ann NY Acad Sci 2001, 938:36-45.
10. Hattori K, Heissig B, Tashiro K, Honjo T, Tateno M, Shieh JH, et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 2001, 97:3354-3360.
11. Schömig K, Busch G, Steppich B, Sepp D, Kaufmann J, Stein A, et al. Interleukin-8 is associated with circulating CD133+ progenitor cells in acute myocardial infarction. Eur Heart J 2006, 27:1032-1037.
12. Vasa M, Fichtlscherer S, Adler K, Aicher A, Martin H, Zeiher AM, et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 2001, 103:2885-2890.
13. Werner N, Priller J, Laufs U, Endres M, Böhm M, Dirnagl U, et al. Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition. Arterioscler Thromb Vasc Biol 2002, 22:1567-1572.
14. Heeschen C, Aicher A, Lehmann R, Fichtlscherer S, Vasa M, Urbich C, et al. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 2003, 102:1340-1346.
15. Pistrosch F, Herbrig K, Oelschlaegel U, Richter S, Passauer J, Fischer S, et al. PPARγ-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells. Atherosclerosis 2005, 183:163-167.
16. Bahlmann FH, de Groot K, Mueller O, Hertel B, Haller H, Fliser D Stimulation of endothelial progenitor cells: a new putative therapeutic effect of Angiotensin II receptor antagonists. Hypertension 2005, 45:526-529.
17. Falcão-Pires I, Leite-Moreira AF Apelin: a novel neuro-humoral modulator of the cardiovascular system. Patho-physiologic importance and potential use as a therapeutic target. Rev Port Cardiol 2005, 24:1263-1276.
18. Kleinz MJ, Davenport AP Emerging roles of apelin in biology and medicine. Pharmacol Ther 2005, 107:198-211.
19. Sheikh AY, Chun HJ, Glassford AJ, Kundu RK, Kutschka I, Ardigo D, et al. In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure. Am J Physiol Heart Circ Physiol 2008, 294:H88-H98.
20. Ronkainen VP, Ronkainen JJ, Hänninen SL, Leskinen H, Ruas JL, Pereira T, et al. Hypoxia inducible factor regulates the cardiac expression and secretion of apelin. FASEB J 2007, 21:1821-1830.
21. Atluri P, Morine KJ, Liao GP, Panlilio CM, Berry MF, Hsu VM, et al. Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression. Cell Mol Biol Lett 2007, 12:127-138.
22. Hashimoto T, Kihara M, Imai N, Yoshida S, Shimoyamada H, Yasuzaki H, et al. Requirement of apelin-apelin receptor system for oxidative stress-linked atherosclero-sis. Am J Pathol 2007, 171:1705-1712.
23. Masri B, Morin N, Cornu M, Knibiehler B, Audigier Y apelin (65-77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells. FASEB J 2004, 18:1909-1911.
24. Gensini GG A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983, 51:606.
25. Rustemeyer P, Wittkowski W, Jurk K, Koller A Opti-mized flow cytometric analysis of endothelial progenitor cells in peripheral blood. J Immunoassay Immunochem 2006, 27:77-88.
26. Lev EI, Kleiman NS, Birnbaum Y, Harris D, Korbling M, Estrov Z Circulating Endothelial Progenitor Cells and Coronary Collaterals in Patients with Non-ST Segment Elevation Myocardial Infarction. J Vasc Res 2005, 42:408-414.
27. Buchwald H Risk reduction and the program on the surgical control of the hyperlipidemias. Circulation 2001, 104:E47.
28. Avogaro P, Crepaldi G, Enzi G, Tiengo A Associazione di iperlipidemia, diabete mellito ed obesità di medio grado. Acta Diabetol Lat 1967, 4:572-590.
29. Fruchart J, Nierman M, Stroes E, Kastelein J, Duriez P New risk factors for atherosclerosis and patient risk as-sessment. Circulation 2004, 109(23S1):III15-III19.
30. Goetze JP, Rehfeld JF, Carlsen J, Videbaek R, Andersen CB, Boesgaard S, et al. Apelin: a new plasma marker of cardiopulmonary disease. Regul Pept 2006, 133(1-3):134-138.
31. Li Z, Bai Y, Hu J Reduced apelin levels in stable angina. Intern Med 2008, 47:1951-1955.
32. Ringqvist I, Fisher LD, Mock M, Davis KB, Wedel H, Chaitman BR, et al. Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). J Clin Invest 1983, 71:1854-1866.
33. Chun HJ, Ali ZA, Kojima Y, Kundu RK, Sheikh AY, Agrawal R, et al. Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis. J Clin Invest 2008, 118:3343-3354.
34. Kadoglou NP, Lampropoulos S, Kapelouzou A, Gkon-topoulos A, Theofilogiannakos EK, Fotiadis G, et al. Serum levels of apelin and ghrelin in patients with acute coronary syndromes and established coronary artery disease-KOZANI STUDY. Transl Res 2010, 155:238-246.
35. Berry MF, Pirolli TJ, Jayasankar V, Burdick J, Morine KJ, Gardner TJ, et al. Apelin has in vivo inotropic effects on normal and failing hearts. Circulation 2004, 110(11 S1):II187-II193.
36. Saint-Geniez M, Masri B, Malecaze F, Knibiehler B, Audigier Y Expression of the murin msr/apj receptor and its ligand apelin is upregulated during formation of the retinal vessels. Mech Dev 2002, 110(1-2):183-186.
37. Cox CM, D'Agostino SL, Miller MK, Heimark RL, Krieg PA Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo. Dev Biol 2006, 296:177-189.
38. Jia YX, Lu ZF, Zhang J, Pan CS, Yang JH, Zhao J, et al. Apelin activates L-arginine/nitric oxide synthase/nitric oxide pathway in rat aortas. Peptides 2007, 28:2023-2029.
39. Kasai A, Shintani N, Oda M, Kakuda M, Hashimoto H, Matsuda T, et al. Apelin is a novel angiogenic factor in retinal endothelial cells. Biochem Biophys Res Commun 2004, 325:395-400.
40. Masri B, Lahlou H, Mazarguil H, Knibiehler B, Audigier Y Apelin (65-77) activates extracellular signal-regulated kinases via a PTX-sensitive G protein. Biochem Biophys Res Commun 2002, 290:539-545.
41. Kasai A, Shintani N, Kato H, Matsuda S, Gomi F, Haba R, et al. Retardation of retinal vascular development ion apelin-deficient mice. Arterioscler Thromb Vasc Biol 2008, 28:1717-1722.
42. Quirici N, Soligo D, Caneva L, Servida F, Bossolasco P, Deliliers GL Differentiation and expansion of endothelial cells from human bone marrow CD133+ cells. Br J Haematol 2001, 115:186-194.
43. Leone AM, Valgimigli M, Giannico MB, Zaccone V, Perfetti M, D'Amario D, et al. From bone marrow to the arterial wall:the ongoing tale of endothelial progenitor cells. Eur Heart J 2009, 30:890-899.
44. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003, 348:593-600.
45. Briguori C, Testa U, Riccioni R, Colombo A, Petrucci E, Condorelli G, et al. Correlations between progression of coronary artery disease and circulating endothelial progenitor cells. FASEB J 2010, 24:1981-1988.
46. Ross R Atherosclerosis- an inflammatory disease. N Engl J Med 1999, 340:115-126.
47. Scheubel RJ, Zorn H, Silber RE, Kuss O, Morawietz H, Holtz J, et al. Age dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2003, 42:2073-2080.
48. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, et al. VEGF contributes to postnatal neo-vascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999, 18:3964-3972.
49. Roberts N, Xiao Q, Weir G, Xu Q, Jahangiri M Endothelial progenitor cells are mobilized after cardiac surgery. Ann Thorac Surg 2007, 83:598-605.
50. Cesari F, Caporale R, Marcucci R, Caciolli S, Stefano PL, Capalbo A, et al. NT-proBNP and the anti-inflammatory cytokines are correlated with endothelial progenitor cells' response to cardiac surgery. Atherosclerosis 2008, 199:138-146.
51. Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003, 362:697-703.
52. Kidoya H, Naito H, Takakura N Apelin induces enlarged and nonleaky blood vessels for functional recovery from ischemia. Blood 2010, 115:3166-3174.